Sung Woo Park

Prof. Sung Woo Park

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Neuropharmacology
Verified
Journal Article
Closed access
MSMi Kyoung Seo
Mi Kyoung Seo
NLNguyen Ngoc Ly
Nguyen Ngoc Ly
CLChan Hong Lee
Chan Hong Lee
HCHye Yeon Cho
Hye Yeon Cho
CCCheol Min Choi
Cheol Min Choi
SPSung Woo Park
Sung Woo Park

21 October 2019 in Brain Sciences
Verified
Journal Article
Open access
PDF file
JLJung Goo Lee
Jung Goo Lee
YWYoung Sup Woo
Young Sup Woo
SPSung Woo Park
Sung Woo Park
DSDae-Hyun Seog
Dae-Hyun Seog
MSMi Kyoung Seo
Mi Kyoung Seo
WBWon-Myong Bahk
Won-Myong Bahk
Melatonin is a hormone that is secreted by the pineal gland. To date, melatonin is known to regulate the sleep cycle by controlling the circadian rhythm. However, recent advances in neuroscience and molecular biology have led to the discovery of new actions and effects of melatonin. In recent studies, melatonin was shown to have antioxidant activity and, possibly, to affect the development of Alzheimer’s disease (AD). In addition, melatonin has neuroprotective effects and affects neuroplasticity, thus indicating potential antidepressant properties. In the present review, the new functions of melatonin are summarized and a therapeutic target for the development of new drugs based on the mechanism of action of melatonin is proposed.

1 April 2014 in Neuropharmacology
Verified
Journal Article
Closed access
MSMi Kyoung Seo
Mi Kyoung Seo
CLChan Hong Lee
Chan Hong Lee
HCHye Yeon Cho
Hye Yeon Cho
JLJung Goo Lee
Jung Goo Lee
BLBong Ju Lee
Bong Ju Lee
SPSung Woo Park
Sung Woo Park

23 December 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MSMi Kyoung Seo
Mi Kyoung Seo
SJSehoon Jeong
Sehoon Jeong
DSDae-Hyun Seog
Dae-Hyun Seog
JLJung An Lee
Jung An Lee
JLJae-Hon Lee
Jae-Hon Lee
JLJung Goo Lee
Jung Goo Lee


26 April 2017 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
MSMi Kyoung Seo
Mi Kyoung Seo
CCCheol Min Choi
Cheol Min Choi
RMRoger McIntyre
Roger McIntyre
HCHye Yeon Cho
Hye Yeon Cho
CLChan Hong Lee
Chan Hong Lee
JLJung Goo Lee
Jung Goo Lee
Recent studies have suggested that the activation of mammalian target of rapamycin (mTOR) signaling may be related to antidepressant action. Therefore, the present study evaluated whether antidepressant drugs would exert differential effects on mTOR signaling in the rat hippocampus under conditions of chronic restraint stress. Male Sprague–Dawley rats were subjected to restraint stress for 6 h/days for 21 days with either escitalopram (10 mg/kg) or paroxetine (10 mg/kg) administered after the chronic stress procedure. Western blot analyses were used to assess changes in the levels of phospho-Ser2448-mTOR, phospho-Thr37/46-4E-BP-1, phospho-Thr389-p70S6 K, phospho-Ser422-eIF4B, phospho-Ser240/244-S6, phospho-Ser473-Akt, and phospho-Thr202/Tyr204-ERK in the hippocampus. Chronic restraint stress significantly decreased the levels of phospho-mTOR complex 1 (mTORC1), phospho-4E-BP-1, phospho-p70S6 K, phospho-eIF4B, phospho-S6, phospho-Akt, and phospho-ERK (p < 0.05); the administration of escitalopram and paroxetine increased the levels of all these proteins (p < 0.05 or 0.01). Additionally, chronic restraint stress reduced phospho-mTORC1 signaling activities in general, while escitalopram and paroxetine prevented these changes in phospho-mTORC1 signaling activities. These findings provide further data that contribute to understanding the possible relationships among mTOR activity, stress, and antidepressant drugs.